Challenges and progress in the development of a serogroup B meningococcal vaccine.

Serogroup B meningococci cause the majority of the meningococcal disease burden in developed countries. Production of an effective and safe vaccine for serogroup B organisms has been hampered by the poor immunogenicity of the capsular polysaccharide that defines this group of bacteria. Previous effo...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Lewis, S, Sadarangani, M, Hoe, J, Pollard, A
বিন্যাস: Journal article
ভাষা:English
প্রকাশিত: 2009